炎症
免疫学
卵清蛋白
免疫系统
医学
分解代谢
亚精胺
代谢途径
巨噬细胞
全身炎症
酶
过敏性炎症
化学
脂氧合酶
药理学
谷氨酰胺分解
过敏
促炎细胞因子
花生四烯酸5-脂氧合酶
生物
胸腺基质淋巴细胞生成素
作者
Y Y He,J H Liu,Z L Yang,Xi Zhang,黄元铭,Liqiong Song,Zhihong Ren
标识
DOI:10.1038/s41522-026-01089-2
摘要
The gut-lung axis is a critical regulator of systemic immune homeostasis, however, the precise mechanisms linking gut-derived metabolites to distal airway inflammation remain incompletely understood. Here, we show that oral administration of viable Leuconostoc mesenteroides MY2024 engages a metabolite-host enzyme circuit that protects against allergic airway inflammation (AAI). Viable, but not heat-inactivated, MY2024 significantly attenuated ovalbumin (OVA)-induced Th2-driven eosinophilic asthma by suppressing pathogenic M2-like macrophage responses in the lung. Mechanistically, MY2024 increased gut-derived cinnamic acid (CA), which activated a colonic STAT1-SAT1 signaling axis to accelerate systemic spermidine catabolism. Reduced systemic spermidine availability was associated with reduced pulmonary eIF5A hypusination, a metabolic checkpoint known to support alternative macrophage activation. Notably, these protective effects and the associated metabolic reprogramming were preserved in microbiota-depleted mice, highlighting a direct bacterium-to-host metabolic axis. Together, our findings delineate a probiotic-metabolite-host enzyme circuit and identify colonic epithelial SAT1-dependent spermidine catabolism as a potential metabolic checkpoint for regulating type 2 AAI.
科研通智能强力驱动
Strongly Powered by AbleSci AI